10 likes | 137 Vues
This graphic illustrates the survival probability percentages over time (in months) for patients not receiving Infliximab treatment after failure. The data suggests a declining survival rate as time progresses, providing crucial insights into the outcomes for patients post-treatment. With a number at risk highlighted at various time points, this figure sheds light on the implications of treatment choices in clinical settings. The research conducted by Oussalah et al. emphasizes the importance of understanding patient survival probabilities.
E N D
100 90 80 70 60 Survival probability without infliximab failure (%) 50 40 30 20 10 0 0 20 40 60 80 Time (months) Number at risk 146 45 14 6 2 Web Figure 2. Oussalah et al.